Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation

Karen Matsukuma, Franklin M. Mullins, Lisa Dietz, James L. Zehnder, James M. Ford, Nicolette M. Chun, Iris Schrijver

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Our patient was a 52-year-old man who was diagnosed with signet ring cell gastric adenocarcinoma. An extensive family history of gastric cancer raised suspicion for hereditary diffuse gastric cancer. Sequencing of the patient's CDH1 gene revealed a novel point mutation in a strictly conserved splice site within intron 6, c.833-2 A > G. This mutation was predicted to result in loss of function due to defective RNA splicing. To characterize the pathogenic mechanism of this mutation, we amplified the patient's CDH1 gene products by reverse transcriptase polymerase chain reaction. Primers flanking the region of the mutation detected 3 distinct transcripts. In addition to the wild-type product, a larger product consistent with activation of a cryptic splice site within intron 6 and a smaller product shown to result from exon 7 skipping were detected. In summary, we have identified a novel CDH1 mutation in a large hereditary diffuse gastric cancer kindred and identified its pathogenic mechanism.

Original languageEnglish (US)
Pages (from-to)1200-1203
Number of pages4
JournalHuman Pathology
Volume41
Issue number8
DOIs
StatePublished - Aug 1 2010
Externally publishedYes

Fingerprint

Stomach Neoplasms
Mutation
Introns
RNA Splicing
RNA Splice Sites
Reverse Transcriptase Polymerase Chain Reaction
Point Mutation
Genes
Exons
Stomach
Adenocarcinoma

Keywords

  • CDH1
  • Gastric cancer
  • HDGC
  • Mutation
  • Splicing

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Matsukuma, K., Mullins, F. M., Dietz, L., Zehnder, J. L., Ford, J. M., Chun, N. M., & Schrijver, I. (2010). Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation. Human Pathology, 41(8), 1200-1203. https://doi.org/10.1016/j.humpath.2010.01.022

Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation. / Matsukuma, Karen; Mullins, Franklin M.; Dietz, Lisa; Zehnder, James L.; Ford, James M.; Chun, Nicolette M.; Schrijver, Iris.

In: Human Pathology, Vol. 41, No. 8, 01.08.2010, p. 1200-1203.

Research output: Contribution to journalArticle

Matsukuma, K, Mullins, FM, Dietz, L, Zehnder, JL, Ford, JM, Chun, NM & Schrijver, I 2010, 'Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation', Human Pathology, vol. 41, no. 8, pp. 1200-1203. https://doi.org/10.1016/j.humpath.2010.01.022
Matsukuma, Karen ; Mullins, Franklin M. ; Dietz, Lisa ; Zehnder, James L. ; Ford, James M. ; Chun, Nicolette M. ; Schrijver, Iris. / Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation. In: Human Pathology. 2010 ; Vol. 41, No. 8. pp. 1200-1203.
@article{1b14623645f947eeb6a180fedcd7c92d,
title = "Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation",
abstract = "Our patient was a 52-year-old man who was diagnosed with signet ring cell gastric adenocarcinoma. An extensive family history of gastric cancer raised suspicion for hereditary diffuse gastric cancer. Sequencing of the patient's CDH1 gene revealed a novel point mutation in a strictly conserved splice site within intron 6, c.833-2 A > G. This mutation was predicted to result in loss of function due to defective RNA splicing. To characterize the pathogenic mechanism of this mutation, we amplified the patient's CDH1 gene products by reverse transcriptase polymerase chain reaction. Primers flanking the region of the mutation detected 3 distinct transcripts. In addition to the wild-type product, a larger product consistent with activation of a cryptic splice site within intron 6 and a smaller product shown to result from exon 7 skipping were detected. In summary, we have identified a novel CDH1 mutation in a large hereditary diffuse gastric cancer kindred and identified its pathogenic mechanism.",
keywords = "CDH1, Gastric cancer, HDGC, Mutation, Splicing",
author = "Karen Matsukuma and Mullins, {Franklin M.} and Lisa Dietz and Zehnder, {James L.} and Ford, {James M.} and Chun, {Nicolette M.} and Iris Schrijver",
year = "2010",
month = "8",
day = "1",
doi = "10.1016/j.humpath.2010.01.022",
language = "English (US)",
volume = "41",
pages = "1200--1203",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation

AU - Matsukuma, Karen

AU - Mullins, Franklin M.

AU - Dietz, Lisa

AU - Zehnder, James L.

AU - Ford, James M.

AU - Chun, Nicolette M.

AU - Schrijver, Iris

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Our patient was a 52-year-old man who was diagnosed with signet ring cell gastric adenocarcinoma. An extensive family history of gastric cancer raised suspicion for hereditary diffuse gastric cancer. Sequencing of the patient's CDH1 gene revealed a novel point mutation in a strictly conserved splice site within intron 6, c.833-2 A > G. This mutation was predicted to result in loss of function due to defective RNA splicing. To characterize the pathogenic mechanism of this mutation, we amplified the patient's CDH1 gene products by reverse transcriptase polymerase chain reaction. Primers flanking the region of the mutation detected 3 distinct transcripts. In addition to the wild-type product, a larger product consistent with activation of a cryptic splice site within intron 6 and a smaller product shown to result from exon 7 skipping were detected. In summary, we have identified a novel CDH1 mutation in a large hereditary diffuse gastric cancer kindred and identified its pathogenic mechanism.

AB - Our patient was a 52-year-old man who was diagnosed with signet ring cell gastric adenocarcinoma. An extensive family history of gastric cancer raised suspicion for hereditary diffuse gastric cancer. Sequencing of the patient's CDH1 gene revealed a novel point mutation in a strictly conserved splice site within intron 6, c.833-2 A > G. This mutation was predicted to result in loss of function due to defective RNA splicing. To characterize the pathogenic mechanism of this mutation, we amplified the patient's CDH1 gene products by reverse transcriptase polymerase chain reaction. Primers flanking the region of the mutation detected 3 distinct transcripts. In addition to the wild-type product, a larger product consistent with activation of a cryptic splice site within intron 6 and a smaller product shown to result from exon 7 skipping were detected. In summary, we have identified a novel CDH1 mutation in a large hereditary diffuse gastric cancer kindred and identified its pathogenic mechanism.

KW - CDH1

KW - Gastric cancer

KW - HDGC

KW - Mutation

KW - Splicing

UR - http://www.scopus.com/inward/record.url?scp=77955083854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955083854&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2010.01.022

DO - 10.1016/j.humpath.2010.01.022

M3 - Article

C2 - 20624523

AN - SCOPUS:77955083854

VL - 41

SP - 1200

EP - 1203

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 8

ER -